These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 8751227)
21. Combined bile acid therapy is more effective on biliary lipids and dissolution rates than monotherapy after gallstone lithotripsy. Tudyka J; Kratzer W; Janowitz P; Mason R; Wechsler JG Am J Gastroenterol; 1995 Nov; 90(11):1942-8. PubMed ID: 7484996 [TBL] [Abstract][Full Text] [Related]
22. Evidence for a potent nucleating factor in the gallbladder bile of patients with cholesterol gallstones. Burnstein MJ; Ilson RG; Petrunka CN; Taylor RD; Strasberg SM Gastroenterology; 1983 Oct; 85(4):801-7. PubMed ID: 6884705 [TBL] [Abstract][Full Text] [Related]
23. Correlation between biliary alpha 1-acid glycoprotein concentration and cholesterol crystal nucleation time in gallstone disease. Nuutinen H; Ginanni Corradini S; Jüngst D; Lange V; Abei M; Schwarzendrube J; Williams C; Holzbach RT Dig Dis Sci; 1995 Jun; 40(6):1174-8. PubMed ID: 7781430 [TBL] [Abstract][Full Text] [Related]
24. Supersaturated bile from obese patients without gallstones supports cholesterol crystal growth but not nucleation. Whiting MJ; Watts JMcK Gastroenterology; 1984 Feb; 86(2):243-8. PubMed ID: 6690352 [TBL] [Abstract][Full Text] [Related]
25. [Nucleation time and lithogenic index in obese patients and in patients with cholecystolithiasis]. Janowitz P; Wechsler JG; Swobodnik W; Fischer S; Förstner J; Ditschuneit H Z Gastroenterol; 1988 Dec; 26(12):750-4. PubMed ID: 3245253 [TBL] [Abstract][Full Text] [Related]
26. Biliary proteins and the nucleation defect in cholesterol cholelithiasis. Gallinger S; Harvey PR; Petrunka CN; Ilson RG; Strasberg SM Gastroenterology; 1987 Apr; 92(4):867-75. PubMed ID: 3556994 [TBL] [Abstract][Full Text] [Related]
27. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Holan KR; Holzbach RT; Hermann RE; Cooperman AM; Claffey WJ Gastroenterology; 1979 Oct; 77(4 Pt 1):611-7. PubMed ID: 467918 [TBL] [Abstract][Full Text] [Related]
28. Pathogenesis of gallstones. Carey MC Recenti Prog Med; 1992; 83(7-8):379-91. PubMed ID: 1529152 [TBL] [Abstract][Full Text] [Related]
29. Bile concentration is a key factor for nucleation of cholesterol crystals and cholesterol saturation index in gallbladder bile of gallstone patients. van Erpecum KJ; van Berge Henegouwen GP; Stoelwinder B; Schmidt YM; Willekens FL Hepatology; 1990 Jan; 11(1):1-6. PubMed ID: 2295460 [TBL] [Abstract][Full Text] [Related]
30. Effect of mucous glycoprotein on nucleation time of human bile. Gallinger S; Taylor RD; Harvey PR; Petrunka CN; Strasberg SM Gastroenterology; 1985 Sep; 89(3):648-58. PubMed ID: 4018505 [TBL] [Abstract][Full Text] [Related]
32. Decreased protein concentration and improved metastability of bile induced by ursodeoxycholate. Chijiwa K; Hirota I; Noshiro H Gastroenterol Jpn; 1992 Feb; 27(1):88-94. PubMed ID: 1555751 [TBL] [Abstract][Full Text] [Related]
33. [Pro-and anti-nucleation activity of biliary proteins in gallbladder bile with and without gallstones]. Zhao YT Zhonghua Yi Xue Za Zhi; 1989 Dec; 69(12):671-3, 46. PubMed ID: 2630013 [TBL] [Abstract][Full Text] [Related]
34. Quantification of cholesterol nucleation promoting activity in human gallbladder bile. Drapers JA; Groen AK; Stout JP; Noordam C; Hoek FJ; Jansen PL; Tytgat GN Clin Chim Acta; 1987 Jun; 165(2-3):295-302. PubMed ID: 3652451 [TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of fine-needle puncture of the gallbladder: side effects, safety, and prognostic value. Tudyka J; Kratzer W; Kuhn K; Janowitz P; Wechsler JG; Adler G Hepatology; 1995 May; 21(5):1303-7. PubMed ID: 7737635 [TBL] [Abstract][Full Text] [Related]
36. Solubility of cholesterol in the crystal-free gallbladder bile of gallstone patients. Jüngst D; Gussmann E; Zündt B; Meyer G; Jüngst C; Del Pozo R; Fischer S J Lab Clin Med; 2004 Sep; 144(3):134-40. PubMed ID: 15454882 [TBL] [Abstract][Full Text] [Related]
37. Nucleation of cholesterol monohydrate crystals from hepatic and gall-bladder bile of patients with cholesterol gall stones. Gollish SH; Burnstein MJ; Ilson RG; Petrunka CN; Strasberg SM Gut; 1983 Sep; 24(9):836-44. PubMed ID: 6884818 [TBL] [Abstract][Full Text] [Related]
38. Comparison of the impact of transdermal versus oral estrogens on biliary markers of gallstone formation in postmenopausal women. Uhler ML; Marks JW; Voigt BJ; Judd HL J Clin Endocrinol Metab; 1998 Feb; 83(2):410-4. PubMed ID: 9467549 [TBL] [Abstract][Full Text] [Related]
39. Biliary alpha 1-acid glycoprotein concentrations in gallstone-free controls and in patients with multiple or solitary cholesterol gallstones. Nuutinen H; Abei M; Schwarzendrube J; Ginanni Corradini S; Walsh RM; Kawczak P; Holzbach RT Dig Dis Sci; 1995 Aug; 40(8):1786-91. PubMed ID: 7648981 [TBL] [Abstract][Full Text] [Related]
40. Biliary proteins in patients with and without gallstones. Hahm JS; Sung IK; Yang SC; Rhee JC; Lee MH; Kee CS; Park KN Korean J Intern Med; 1992 Jan; 7(1):18-24. PubMed ID: 1477026 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]